|
Bio-Rad Laboratories, Inc.
|
|
|
|
The BioPlex® 2200 ANA Screen is intended for the qualitative screening of specific antinuclear antibodies (ANA), the quantitative detection of antibody to dsDNA, and the semi-quantitative detection of twelve (12) separate antibody assays (Chromatin, Ribosomal Protein, SS-A 52†, SS-A 60†, SS-B, Sm, SmRNP, RNP A†, RNP 68†, Scl-70, Jo-1, and Centromere B) in human serum and/or EDTA or heparinized plasma. The test system is used as an aid in the diagnosis of systemic rheumatic diseases.
|